guidelines for harvesting, storage etc of herbal plants
TRANSCRIPT
AP-CF/Guidelines-GMCL & LAB/Final
GUIDELINES FOR HARVESTING,
STORAGE, DRYING AND GRADING &
STRUCTURES REQUIRED FOR VALUE
ADDITION AND STORAGE
PREPARED FOR ANDHRA PRADESH FOREST DEPARTMENT
GMCL & LAB
JULY 2002
AP-CF/Guidelines-GMCL & LAB/Final
GUIDELINES FOR HARVESTING,
STORAGE, DRYING AND GRADING &
STRUCTURES REQUIRED FOR VALUE
ADDITION AND STORAGE
PREPARED FOR ANDHRA PRADESH FOREST DEPARTMENT
Contributors : G. RAJU
Dr. M.S. Sastry
GMCL & LAB
AP-CF/Guidelines-GMCL & LAB/Final
1
Value Addition to Raw drugs
In the Report on “Value Addition Techniques for commercially important medicinal
plants of Andhra Pradesh including Pharmacoepial standards for 61 species ”, discussion
on good storage practices, drying methods etc., have been provided.
The following section discusses the value addition route to raw drugs.
Ayurvedic formulation: This route can ensure a value addition in the range of 4-10
times or more. Ayurvedic formulation can be made from the Ayurvedic Formulary of
India, a standard reference for this purpose. The technology involved is simple. There are
a plethora of products and the consumer may have a problem in differentiating a good
quality product from a spurious one. The market survey reveals that the products are not
formulated on any standards. Each company makes its own formulations and the claims
are not substantiated. Even if the enterprise was to make genuine products the challenge
will be to build an image of quality. It is expected that the market for herbal products will
grow to about Rs 4000 crores by about 2002 AD. So while there is space for introducing
formulations the challenge will be to build a brand image. Export of such products is
another avenue of opportunity. The table 1 gives an idea of market of different products
that are produced from the species that we have identified.
Table:1 Prices of Sample ProductsSl. no plant name price of
crudedrug
singleproduct
Price Mixed product Price
1 A. paniculata 20.00 churan With H.a* 300.002 M. pruriens 30.00 churan 70.00 Vanari kalpa 225.00
3 C. borivilianum 200.0 Capsule 240.00 per100
4 H. antidysentrica 13.00 200mlcontaining25gms
40.00
5 G. sylvestre 10.00 churan 80.00* H.antidysentricaSource: Raju and Singh (1997) : Feasibility Study of a Non-timber forest produce enterprise.Working paper. Institute of Rural Management, Anand
AP-CF/Guidelines-GMCL & LAB/Final
2
The table 2 gives the number of formulations that are possible based on the Ayurvedic
Formulary of India that was mentioned earlier.
Table:2 Ayurvedic formulations containing selected medicinal plants
Sl.No. Medicinal Plants No. of Formulations
1 Andrographis paniculata 242 Butea monosperma 83 Cassia fistula 104 Cassia tora 35 Chlorophytum tuberosum 56 Curculigo orchioides 27 Hemidesmus indicus 418 Holarrhena antidysenterica 309 Mucuna pruriens 710 Phyllanthus amarus 911 Semecarpus anacardium 1512 Strychnos nux-vomica 113 Woodfordia fruticosa 36
Source: Raju and Singh (1997) : Feasibility Study of a Non-timber forest produce enterprise.Working paper. Institute of Rural Management, Anand
The table 3 gives a general break-up of the market share of categories of products
(ITCOT, 1996). Based on this table one can decide the categories of products that can be
made and sold.
Table 3 Market share of products
Product category % shareArishtas 30Medicated oils 20Lehas 20Kashayams 10Medicated ghee 10Pills, powders and raskariyas 10
Source: Raju and Singh (1997) : Feasibility Study of a Non-timber forest produce enterprise.Working paper. Institute of Rural Management, Anand
AP-CF/Guidelines-GMCL & LAB/Final
3
Extracts: This route requires a more sophisticated technology. The following plants yield
extractions that have a demand in the market place. A. paniculata, G. sylvestre, Strychnos
nux-vomica, P. amarus, M. pruriens and others such as B. monosperma, S. anacardium
yield extracts that have industrial applications. In this route value addition to the extent of
10 times is possible. The technology required is one of solvents extraction with various
solvents required for extraction purposes. The extracts also have a demand in the export
segment.
Table 4: Export Potential
Sl. no Item of export Value in Rs in lakhs per tonne
1 Sarasparilla* 0.645
2 Nux-vomica salts and derivatives 11.494
3 Strychnine alkaloids 7.67
4 Emetine alkaloids** 422
5 Emetine salts and derivatives 317
* S. zeylanica is used as a substitute.** The plants Holarrhena antidysentrica have emetic properties.Source: Raju and Singh (1997) : Feasibility Study of a Non-timber forest produce enterprise.Working paper. Institute of Rural Management, Anand
Table 4 gives a picture regarding the export market and the table 5 gives an idea of the
domestic market prices. In the domestic market likewise in crude drug market the quality
of extracts is also considered a problem. The enterprise could use it as an advantage and
supply good quality extracts to other companies that make formulations based on these
extracts. In this sector not many players are there and hence an image could be more
easily established as compared to the crude drug segment.
AP-CF/Guidelines-GMCL & LAB/Final
4
Table 5 Some market price of Extracts
Plant name Price per kg of concentratedextracts of Company A
Price of Extracts of Company B
1=25kg ofcrude drug
1=100kg ofcrude drug
Product type Price
Ipomea nil 435.00 1380.00Mucuna pruriens 420.00 1290.00 8% L-Dopa 35.00*Gymnema sylvestre 225.00 480.00P. niruri 495.00 1584.00 1=10kg 450.00W. fruticosa 165.00 303.00C. angustifolia 435.00 1380.00 1250.00
(15% senocide)S. nux-vomica 4-8% striccine 95.00 per %H. antidysentrica 30.00 per %A. paniculata 525.00 1695.00 8%
Andrographalide
35.00* per %
Source: Raju and Singh (1997) : Feasibility Study of a Non-timber forest produce enterprise.Working paper. Institute of Rural Management, Anand
Technological Process:
Crude Drugs: In case of the crude drugs plant material is collected in the appropriate
season and time of the day. Leaves are collected from plants during the flowering season
when the plant is very active. The sap movement and photosynthetic activity are at a
maximum and leaves contain maximum of the active constituents. Bark is collected in
spring or early summer. In this season cambium is very active and since its cell walls are
very thin bark gets separated very easily. Flowers are collected about the time of
pollination in dry weather in the forenoon when the dew has disappeared and dried in
shade. Roots and tubers are collected in autumn when the plant is inactive and the
vegetative process has ceased and contain the maximum active constituents. Once the
plant material is collected it is dried either in shade or in sun and stored. Impurities are
then removed. Then the plant material is ready to be packed and transported as crude
drugs to the end user companies.
AP-CF/Guidelines-GMCL & LAB/Final
5
Ayurvedic Formulations: Ayurvedic formulations are made in the form of choorna,
lehya, gutika, rasayans, ointment, oils etc. Use of modern technology in the
manufacturing process like grinding, crushing, mixing, tabletting, packing could be
made. The entire process could also be done manually using kitchen equipment of large
capacity. The Ayurvedic Formulary of India, like a recipe, gives the individual
ingredients that are required and the quantity required of each constituent and the process
involved. Hence no difficulty is anticipated in its manufacture. The Government of India
has prescribed Good Manufacturing Practices (GMP) which is dealt in a separate section.
Extraction Technology: The process involves pulverising the crude drug, extraction
with solvents such as water, alcohol, chloroform, acetone etc and the concentration of
extract to a paste constituency, vacuum drying, centrifuging in the case of some products,
pressure filtration, spray drying, powdering to a fine mesh and vacuum packing. As the
products are utilised for pharmaceutical and cosmetic industry a great deal of care needs
to be given to the Goods Manufacturing Practices, such as the use of stainless steel
equipment, quality of process water used, maintenance of sterile manufacturing facility,
quality control and quality assurance and the continuous analysis of products throughout
the manufacturing cycle.
Some extraction processes are illustrated in Annexure-I
Good Manufacturing Practices (GMP): Some Salient Features: The Good
Manufacturing Practices are prescribed to ensure that:
1. Raw materials used in the manufacture of drugs are authentic, of prescribed quality
and are free from contamination.
2. The manufacturing process is as has been prescribed to maintain the standards
3. Adequate control measures are adopted and
4. The manufactured drug which is released for sale is of acceptable quality.
5. To achieve the above objectives listed , each licenses shall evolve methodology and
procedures for following the prescribed process of manufacturing the which should
be documented as manual and kept for reference and inspection.
AP-CF/Guidelines-GMCL & LAB/Final
6
Factory Premises: The manufacturing plant should have adequate space for
a) Receiving and storage of raw material
b) Manufacturing process areas
c) Quality control section
d) Finished goods store
e) Office
f) Rejected goods/drug store
General Requirements
Location and Surroundings
The factory buildings for manufacture of ayurveda, siddha and unani medicines shall be
so situated and shall have such construction as to avoid contamination from open sewage,
drain, public lavatory or any factory which produces disagreeable or obnoxious odour or
fumes or excessive soot, dust or smoke.
Buildings
The building used for factory shall be as such as to permit production of drugs under
hygienic conditions and should be free from cobwebs and insects/rodents. It should have
adequate provision of light and ventilation. The floor and the walls should not be damp or
moist. The premises used for manufacturing, processing, packaging and labelling will be
in conformity with the provisions of the Factory Act. It shall be located as to be :
a) Compatible with other manufacturing operations that may be carried out in the same
way or adjacent premises.
b) Adequately provided with working space to allow orderly and logical placement of
equipment and materials to avoid the risk of mix up between different drugs or
components thereof and control the possibility of cross contamination by other drugs
or substances and avoid the risk of omission of any manufacturing or control step:
AP-CF/Guidelines-GMCL & LAB/Final
7
c) Designed, constructed and maintained to prevent entry of insects/rodents. Interior
surface (walls, floors and ceilings) shall be smooth and free from cracks and permit
easy cleaning and dis-infection. The walls of the room in which the manufacturing
operations are carried out shall be impervious to and be capable of being kept clean.
The flooring shall be smooth and even and shall be such as not to permit retention or
accumulation of dust or waste products.
d) Provided with proper drainage system in the processing area. The sanitary fitting and
electrical fixtures in the manufacturing area shall be proper and safe.
e) Furnace/bhatti section could be covered with tin roof and proper ventilation, but
sufficient cares should be taken to prevent flies and dust.
f) There should be fire safety measures and proper exits should be there.
Water supply
The water used in manufacture shall be pure and of potable quality. Adequate provision
of water for washing the premises shall be made.
Disposal of waste
From the manufacturing sections and laboratories the waste water and the residues which
might be prejudicial to the workers or public health shall be disposed off after suitable
treatment as per guidelines of pollution control authorities to render them harmless.
Containers Cleaning
In factories where operations involving the use of containers such as bottles, vials and
jars are conducted, there shall be adequate arrangements separated from the
manufacturing operations for washing, cleaning and drying of such containers.
Stores
Storage should have proper ventilation and shall be free from dampness. It should
provide independent adequate space for storage of different types of material, such as raw
material, packaging material and finished products.
AP-CF/Guidelines-GMCL & LAB/Final
8
Raw Materials
All raw materials procured for manufacturing will be stores in the raw materials store.
The manufacture based on the experience and the characteristics of the particular raw
material used in ISM system shall decide the use of appropriate containers which would
protect quality of the raw material. (See Good storage practice). The raw material should
be segregated depending on the source as follows: metallic origin, animal, mineral, fresh,
dry, volatile oils etc and plant extracts. Labelling as suggested should be adhered to.
Packaging Materials
All packaging material shall be stored properly. All packing material should be cleaned
before use for packing and storing.
Finished Goods Stores
The finished goods transferred from the production area after proper packaging shall be
restored in the finished goods stores within an area marked “Quarantine”. After the
quality control laboratory and the experts have checked the correctness of finished goods
with reference to its packing/labelling as well as the finished good quality as prescribed,
then it will be moved to “ approved finished goods stock” area. Only approved finished
goods shall be dispatched as per marketing requirements. Distribution records shall be
maintained as required.
Equipments
For carrying out manufacturing depending on the size of operation and the nature of
product manufactured suitable equipment either manually operated or operated semi-
automatically or fully automatic machinery shall be made available. These equipments
have to be properly installed and maintained with proper cleaning. Proper standard
operational procedures for cleaning, maintaining and performance of every machine
should be laid down.
AP-CF/Guidelines-GMCL & LAB/Final
9
Quality Control
Every licensee is required to provide facility for quality control section in his own
premises or through Government approved testing laboratory. The tests shall be as
prescribed in ISM pharmacopoeial standards. The quality control section shall verify all
the raw materials, monitor in process quality checks and control the quality of finished
product released to finished goods store/warehouse. Further the GMP norms defines the
space and other requirements of such a facility.
(The GMP further discusses on “working space”, health clothing, sanitation and hygiene
of workers, medical services to workers, Requirement of sterile product manufacturing
area, batch manufacturing records, record of market complaints,. For brevity sake the
details are not provided. The GMP can be obtained from ISM Department, Ministry of
Health)
AP-CF/Guidelines-GMCL & LAB/Final
FRLHT Source : Standardisation of Botanicals – Vol 1 (2002) Eastern Publishers, New Delhi
ANNEXURE I
SEMI PROCESSING OF THE MEDICINAL PLANTS NATIVE TO ANDHRAPRADESH FOR VALUE ADDITION
Acorus calamus
Extract :
The rhizomes are extracted with ethyl alcohol or methyl alcohol at 65 – 70 0 C aftersoaking the material for 2 hours. The solvent from the extract is completely removedunder vacuum and the residue mixed with excipients is dried under vacuum. The driedproduct is powdered.
Aloe barbadensis
The plant yields two commercially important products:
1. Aloe :- The latex from the Pericyclic cells beneath the skin of the leavesis evaporated and the solid residue so obtained is the commercialaloe. It is bitter and used as a purgative.
2. Aloe gel:- It is a thin gelatinous material obtained by crushing themucilagenous cells in the inner tissue of the leaf. The epidermis ofthe leaves is removed to get mucilagenous parenchyma andhomogenised. It is diluted with water, filtered and concentratedunder reduced pressure to obtain 5% solids or as per requirements.This gel is used in cosmetics.
Aloe gel obtained as above is concentrated under reduced pressureto contain 15% solids and then spray dried to convert it into aloegel powder.
Andrographis paniculata
Extract:
The crushed plant material is extracted with 70% alcohol and after removing the solventat 55 0 C under vacuum, the extract is homogenised and spray dried.
AP-CF/Guidelines-GMCL & LAB/Final
FRLHT Source : Standardisation of Botanicals – Vol 1 (2002) Eastern Publishers, New Delhi
Bacopa monnieri
Extract:
The crushed plant material is extracted with 70% alcohol in counter current extractors.The extract so obtained is concentrated and the resinous matter is separated. The resinfree extract is further concentrated in a falling film evaporator to a consistency of 30%solids and spray dried.
Boswellia serrata
Gum:
The gum collected from the medicinal plant is cleared from the adhering material andextracted with alcohol. These extracts are partially distilled and pH adjusted to slightlyabove 7. It is then extracted with petroleum ether in a liquid – liquid extractor.Alcoholic fraction is concentrated to contain 35% solids and poured into deminerlisedwater with stirring to precipitate Boswellic acid, rich fraction. This precipitate isseparated and dried under vacuum.
Cassia senna
Extract:
Senna leaves powder containing about 2.5% sennosides are extracted with acetone andthen with 70% alcohol or methyl alcohol pre-adjusted to pH 3.9 with citric acid. Theextract is treated with lime water and pH is adjusted to 6.0 – 6.2 and concentrated to apaste with 65 – 70% solids content in a multiple effect evaporator. The paste is thendried in a rotary vacuum evaporator at 50 – 550C.
Centella asiatica
Extract:
Powdered plant material is extracted with alcohol and then with water. The combinedextracts are concentrated to a thick paste under vacuum at 550C in a falling filmevaporator. The paste is defatted with n-hexane under reflux for one hour. The defattedmaterial is mixed with suitable additives and the paste is dried under vacuum in a rotarydryer.
AP-CF/Guidelines-GMCL & LAB/Final
FRLHT Source : Standardisation of Botanicals – Vol 1 (2002) Eastern Publishers, New Delhi
Eclipta alla
Extract:
Plant material is extracted with 90% methanol and then with 50% methanol. The extractis concentrated and dried under vacuum. The flakes obtained are powdered.
Gymnema sylvestre
Extract:
Powdered leaves are extracted with 55% alcohol and the extract concentrated underreduced pressure to contain 30% solids. The concentrated extract is dried in spray dryerto obtain homogenised powder.
Mucuna pruriens
Extract:
Powdered seeds are extracted with demineralised water containing 1% acetic acid. Theconcentrated extract is spray dried. The moisture content of the powder is maintainedbelow 3%.
Phyllanthus amarus
Extract:
The plant material generally found to be contaminated with fungus and bacteria is firstdecontaminated and extracted with a pure polar solvent followed with a dilute solvent.Both the extracts are concentrated separately and mixed in a definite strength to get theextract in a paste form. The paste is then dried at reduced pressure after mixing withwater soluble starch and pulverised. Moisture content should not be more than 4%.
Tinospora cordifolia
The well matured stems are powdered and extracted with 50% alcohol followed withdemineralised water. The extracts are concentrated separately, mixed and furtherconcentrated. The concentrate is spray dried to a thick paste containing 65 – 70% solids,which is then dried in a vacuum tray dryer and powdered.
AP-CF/Guidelines-GMCL & LAB/Final
FRLHT Source : Standardisation of Botanicals – Vol 1 (2002) Eastern Publishers, New Delhi
Tribulus terrestris
Extract:
The powdered fruits are soaked in 55% alcohol and then extracted repeatedly with thesame solvent. The extract is concentrated to attain a consistency of 30-35% solidscontents and sterlised. The sterlised extract is spray dried and powdered.
Withania somnifera
Extract:
Powdered roots are extracted with 55% alcohol in a counter current extractor and theextract is concentrated under vacuum at 550C and then spray dried.